NCT00566046 - Prevention of Post-traumatic Seizures With Levetiracetam | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

May 31, 2010

Conditions

Epilepsy, Post-Traumatic

Interventions

DRUG

Levetiracetam

1500 mg/day orally until the first episode of late epilepsy for a maximum duration of 3 months

DRUG

Placebo

1500 mg/day orally until the first episode of late epilepsy for a maximum duration of 3 months

Trial Locations (15)

Neurologie - CHU Rennes, Rennes

Neurochirurgie-Paris Saint Anne, Paris

Neurologie - CHU Angers, Angers

Neurology - CHU Bordeaux, Bordeaux

Neurologie - CHU Caen, Caen

Neurochirurgie-CHU Grenoble, Grenoble

Neurology - CHU Rennes, Grenoble

Neurophysiologie Clinique - CHU Lille, Lille

Neurophysiologie clinique - CHU Lyon (Hôpital neurologique), Lyon

Beurophysiologie clinique - CHU Marseille, Marseille

Epileptologie - CHU Montpellier, Montpellier

Neurologie - CHU Nancy, Nancy

Explorations Fonctionnelles Neurologiques - CHU Nantes, Rennes

Neurologie - CHU Rouen, Rouen

Neurologie - CHU Tours Hopital Trousseau, Tours